Publications by authors named "M E Yiu"
Paediatric Uveitis - the uniqueness in clinical presentation and the efficacy of biologics treatment.
J Ophthalmic Inflamm Infect
July 2024
Article Synopsis
- This study investigates pediatric uveitis characteristics and treatment outcomes at a local tertiary eye center, focusing on the effectiveness of biologic therapies.
- A total of 37 pediatric uveitis cases were analyzed, revealing a mean onset age of 11 years, with a high incidence of bilateral (81.1%) and chronic uveitis (75.7%).
- Notably, idiopathic uveitis was the most common diagnosis, and systemic conditions outlined include Behçet's disease, highlighting differences in presentation compared to other populations, particularly in treatment responses requiring immunotherapy and biologics.
Background: Individuals with major depressive disorder have a cognitive bias toward emotional stimuli, which influences the quality and speed of emotional information processing. This study aimed to understand the factors underlying this bias by identifying when it occurs during information processing using an information processing model.
Methods: A total of 57 participants-19 each [ (16 (84.
Background And Objective: Conventionally, standard resection (SR) is performed by resecting the bladder tumour in a piecemeal manner. En bloc resection of the bladder tumour (ERBT) has been proposed as an alternative technique in treating non-muscle-invasive bladder cancer (NMIBC). The objective of this study is to investigate whether ERBT could improve the 1-yr recurrence rate of NMIBC, as compared with SR.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the impact of early intervention (EI) services on adults aged 26-55 with adult-onset psychosis, comparing its effectiveness against standard care (SC).
- Results show that a 4-year EI program leads to better social functioning and lower symptom severity compared to SC, particularly notable in the first two years.
- The findings suggest that at least two years of specialized EI treatment is beneficial for this age group, but extending it to four years offers minimal additional advantages.
This study investigated if immunomodulatory treatment improves the in-vitro fertilization (IVF) success rates of women with two or more recurrent pregnancy losses (RPL) and repeated implantation failures (RIF) with cellular immune abnormalities and thrombophilia. We performed a retrospective cohort study of 197 RPL patients who received immunomodulatory and anticoagulation treatment undergoing IVF cycles (fresh or frozen embryo transfer). Patients were divided into four groups; Group 1: women with RPL but without RIF, Group 2: women with RPL and RIF (≥3), Group 3: women with RPL after IVF cycles (>2) and without RIF, and Group 4: women with RPL after IVF cycles and RIF.
View Article and Find Full Text PDF